LMR Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.96M Buy
649,082
+344,748
+113% +$3.85M 0.02% 583
2026
Q1
$3.3M Buy
+304,334
New +$2.61M 0.01% 752
2023
Q3
Sell
-1,000,000
Closed -$12M 1016
2023
Q2
$12M Buy
+1,000,000
New +$11.3M 0.13% 169
2017
Q4
Sell
-43,419
Closed -$910K 391
2017
Q3
$910K Sell
43,419
-156,581
-78% -$2.88M 0.1% 109
2017
Q2
$4.04M Hold
200,000
0.25% 70
2017
Q1
$4.85M Buy
+200,000
New +$5.39M 0.47% 42

Other funds holding PTEN

LMR Partners's PTEN Position: Q2 2026 in Review

LMR Partners increased its Patterson-UTI (PTEN) stake by 113% in Q2 2026, buying an estimated $3.85M and bringing the position to 649,082 shares worth $5.96M. The position accounts for 0.02% of the portfolio, ranked #583.

LMR Partners first reported a position in PTEN in Q1 2017 and has held it in 6 quarters since. The position peaked at $12M in Q2 2023. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • LMR Partners held 649,082 shares of Patterson-UTI worth $5.96M as of Q2 2026.
  • LMR Partners bought 344,748 Patterson-UTI shares in Q2 2026, an estimated $3.85M.
  • Patterson-UTI made up 0.02% of LMR Partners's portfolio in Q2 2026, its #583 holding.
  • LMR Partners first reported a position in Patterson-UTI in Q1 2017 and has held it in 6 quarters since.
  • LMR Partners's Patterson-UTI position peaked at $12M in Q2 2023.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.